Earnings call transcript: OHB SE Q1 2026 sees strong growth and stock surge

OHB SE posted Q1 2026 revenue of EUR 200.8 million, up 15% year over year, with adjusted EBITDA of EUR 27.3 million and a record order backlog of more than EUR 3.35 billion. The stock rose 6.57% in pre-market trading after the update, supported by major contract wins including EPS-Sterna, RAMSES, and further Eaglet II launches. Management was constructive on future growth but did not provide specific 2026 revenue guidance.

Analysis

The key read-through is not simply that OHB is executing well; it is that the company is moving from a project-by-project contractor to a backlog-backed manufacturing platform with improving visibility. That shifts the valuation debate from near-term margin cyclicality to medium-term capacity absorption, and it is why the stock can keep rerating even if headline growth normalizes. The market may still be underestimating how much of the order book is now effectively de-risked by European institutional funding cycles, which can create a multi-quarter revenue pipeline rather than a single-quarter beat.

The second-order beneficiary is the broader European space supply chain. A bigger OHB implies more demand for subsystem vendors, electronics, propulsion, launch services, and specialized engineering labor; the bottleneck is increasingly talent, not demand. That matters because tight labor conditions should support pricing power for niche suppliers while compressing margins for lower-value-added integrators that cannot recruit or qualify capacity fast enough.

The contrarian risk is that the stock may be ahead of fundamentals in the near term. With the shares already reflecting a scarcity premium and backlog visibility, incremental upside likely depends on conversion quality: launch execution, contract timing, and whether defense programs clear procurement and parliamentary hurdles on schedule. The market is also likely to overestimate how much of the defense budget inflection drops straight to OHB; in practice, the mix will be fragmented across primes, so the real alpha is in identifying the suppliers with the cleanest capacity expansion and fastest delivery cycle.

Catalyst timing is asymmetric: positive news can come over days to weeks from launch/test milestones and contract awards, while downside from execution issues would likely show up over months. The clearest tail risk is a launch setback or an institutional delay that pushes revenue into later periods without fully offsetting fixed-cost buildup. That creates a good setup for selective longs in the value chain, but a less attractive case for chasing the prime after a strong post-print move.

Key Decisions for Investors

• Long OHB SE on pullbacks over the next 2-4 weeks, but size modestly: backlog and defense exposure support a rerating, while the current move already prices in near-term perfection; target 8-12% upside versus 5-7% downside if execution slips.
• Pair trade: long OHB suppliers with higher operating leverage to capacity expansion vs. short a European industrials basket over 1-3 months; thesis is that space labor and component scarcity create pricing power for specialized vendors while broad industrials do not get the same budget tailwind.
• Buy a small call spread into the next launch/test milestone or capital markets update; catalyst-driven upside is likely to be faster than consensus expects, but the trade should be structured for limited premium at risk because launch execution remains binary.
• Avoid chasing the stock after the pre-market spike; wait for any post-event consolidation, since the near-term valuation is vulnerable to 'good but not enough' reaction if management does not convert backlog into cleaner margin expansion.
• Monitor European defense-adjacent names for second-order beneficiaries, but prefer pure-play space exposure over large primes where budget reallocation risk is highest; the best risk/reward is where incremental contract wins can move estimates materially within 2 quarters.